Airtime: ET
Big pharma is embracing social media, but how much can or should a tightly regulated sector be able to say on Facebook or Twitter? CNBC's Mike Huckman takes a closer look.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
CNBC's Bill Griffeth looks ahead to next week's top business and financial stories.
The Options Action traders discuss viewer mail, with CNBC's Melissa Lee.
The Options Action traders discuss the trades their looking at next week, with CNBC's Melissa Lee.